Alcidion Group (ASX:ALC) Ending Cash Position: A$14.20 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Alcidion Group Ending Cash Position?

Alcidion Group ASX:ALC +1.04% Ending Cash Position is A$14.20 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Alcidion Group's Ending Cash Position for the quarter that ended in Dec. 2025 was A$14.20 Mil.

Alcidion Group's quarterly Ending Cash Position increased from Dec. 2024 (A$7.68 Mil) to Jun. 2025 (A$17.70 Mil) but then declined from Jun. 2025 (A$17.70 Mil) to Dec. 2025 (A$14.20 Mil).

Alcidion Group's annual Ending Cash Position declined from Jun. 2023 (A$14.64 Mil) to Jun. 2024 (A$11.80 Mil) but then increased from Jun. 2024 (A$11.80 Mil) to Jun. 2025 (A$17.70 Mil).

Alcidion Group Ending Cash Position Related Terms

Alcidion Group Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Alcidion Group's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alcidion Group Ending Cash Position Chart

Alcidion Group Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.03 17.34 14.64 11.80 17.70

Alcidion Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.91 11.80 7.68 17.70 14.20

Alcidion Group Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Alcidion Group's Ending Cash Position for the fiscal year that ended in Jun. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=11.798+5.899
=17.70

Alcidion Group's Ending Cash Position for the quarter that ended in Dec. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=17.697+-3.502
=14.20

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of A$14.20 Mil mean?
Alcidion Group (ASX:ALC) has a Ending Cash Position of A$14.20 Mil as of Dec. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Alcidion Group and its competitors.
Is Alcidion Group's Ending Cash Position too high?
Alcidion Group's current Ending Cash Position is A$14.20 Mil.
How does Alcidion Group's Ending Cash Position compare to VEEV and BTSG?
Alcidion Group's Ending Cash Position of A$14.20 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Alcidion Group and its competitors. Alcidion Group's current Ending Cash Position is A$14.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcidion Group stock overvalued right now?
Based on GuruFocus' analysis, Alcidion Group (ASX:ALC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.12, compared to a current price of A$0.10 — trading 19.2% below its estimated fair value. The current Ending Cash Position is A$14.20 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Alcidion Group (ASX:ALC), the current Ending Cash Position is A$14.20 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alcidion Group Business Description

Address 9 Yarra Street, Level 10, South Yarra, Melbourne, VIC, AUS, 3141
Alcidion Group Ltd is a provider of intelligent informatics software. It offers a fully integrated digital patient care platform that includes a clinical decision support (CDS) system, Electronic Patient Record (EPR), and Patient Administration System (PAS). Alcidion is engaged in the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of healthcare software products from its strategic partners, and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in the United Kingdom, Australia, and New Zealand. The company generates maximum revenue from the United Kingdom.